Risk factor
Considerable default risk
Profitability factor
Greatly overvalued vs peers
About
Samsara Vision, Inc. operates as a specialty medical device company that engages in the research, development, manufacture, and marketing of implantable ophthalmic devices, and technologies for individuals with untreatable retinal disorders. The company offers Implantable Miniature Telescope (IMT), an implantable medical device to improve vision and quality of life in individuals with end-stage age-related macular degeneration (AMD); Smaller-Incision, New Generation IMT, an injectable device; and TSert delivery system. The company was formerly known as VisionCare Inc and changed its name to Samsara Vision, Inc. in September 2020. Samsara Vision, Inc. was founded in 1997 and is headquartered in Far Hills, New Jersey.
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Buy
Sell